NewsRx

Search our medical news database

Anthrax

BioShield Announces 99.999% Kill Rate

Published in TB and Outbreaks Week, January 15th, 2002

BioShield Technologies, Inc., announced December 17, 2001, that it has received independent laboratory tests results that proves the efficacy of BioShield products against anthrax spores and Bacillus anthracis.

Qualified microbiologists, currently working on anthrax testing at a university laboratory, finished first tests with BioShield's new formulation proving the efficacy against B. anthracis spores and the bacteria that causes anthrax. The information has been compiled and submitted to the U.S. Environmental Protection Agency (EPA) for review and consideration. If accepted, BioShield Technologies (BSTI) will be able to offer this product to the...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook